COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their effectiveness as worrisome new virus variants arise.
COVID-19 dual-antibody therapies effective against variants in animal study
June 21, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022